The Journal of Immunology, Vol 144, Issue 1 244-250, Copyright © 1990 by American Association of Immunologists

ARTICLES

Treatment with dexamethasone down-regulates IgE-receptor-mediated signals and up-regulates adenosine-receptor-mediated signals in a rat mast cell (RBL-2H3) line

D Collado-Escobar, JR Cunha-Melo and MA Beaven
Laboratory of Chemical Pharmacology, National Heart Lung and Blood Institute, Bethesda, MD 20892.

As reported by other workers, the treatment of rat basophilic leukemia RBL-2H3 cells with dexamethasone resulted in a marked decrease in responsiveness to Ag-stimulation. All responses measured, which included hydrolysis of inositol phospholipids, increase in concentration of cytosolic Ca2+, release of arachidonic acid and the secretion of serotonin, were suppressed, but once the cells were permeabilized the inhibitory actions of dexamethasone were no longer apparent. This suggested that all the necessary components of the stimulatory cascade were intact in the dexamethasone-treated cells. The measurement of phospholipase C activity in cell extracts and studies with phorbol ester also indicated that the cells contained a normal complement of phospholipase C and protein kinase C activity. We had previously shown that both Ag and the adenosine analog, 5'-(N- ethylcarboxamide)-adenosine, can activate phospholipase C, but they do so through different G proteins. Interestingly, the activation of phospholipase C by 5'-(N-ethylcarboxamide)-adenosine and the ensuing stimulatory events were markedly enhanced in dexamethasone-treated cells. The treatment with dexamethasone thus did not result in direct suppression of effector systems, but instead resulted in the selective modulation of the coupling between receptors and the effector systems by mechanisms that require soluble cytosolic factors.

This article has been cited by other articles:

				T. Hiragun, Z. Peng, and M. A. Beaven Cutting Edge: Dexamethasone Negatively Regulates Syk in Mast Cells by Up-Regulating Src-Like Adaptor Protein J. Immunol., August 15, 2006; 177(4): 2047 - 2050. [Abstract] [Full Text] [PDF]

				T. Hiragun, Z. Peng, and M. A. Beaven Dexamethasone Up-Regulates the Inhibitory Adaptor Protein Dok-1 and Suppresses Downstream Activation of the Mitogen-Activated Protein Kinase Pathway in Antigen-Stimulated RBL-2H3 Mast Cells Mol. Pharmacol., March 1, 2005; 67(3): 598 - 603. [Abstract] [Full Text] [PDF]

				A. C. Cruz, T. S. Hall, K. D. Jones, S. T. Edwards, and K. C. Fang Induction of Mast Cell Activation and CC Chemokine Responses in Remodeling Tracheal Allografts Am. J. Respir. Cell Mol. Biol., August 1, 2004; 31(2): 154 - 161. [Abstract] [Full Text] [PDF]

				M. V. M. Andrade, T. Hiragun, and M. A. Beaven Dexamethasone Suppresses Antigen-Induced Activation of Phosphatidylinositol 3-Kinase and Downstream Responses in Mast Cells J. Immunol., June 15, 2004; 172(12): 7254 - 7262. [Abstract] [Full Text] [PDF]

				J. P. Hannon, B. Tigani, H.-J. Schuurman, and J. R. Fozard Suppression of Adenosine A3 Receptor-Mediated Hypotension and Mast Cell Degranulation in the Rat by Dexamethasone J. Pharmacol. Exp. Ther., August 1, 2002; 302(2): 725 - 730. [Abstract] [Full Text] [PDF]

				G. T. Furuta, S. J. Ackerman, L. Lu, R. E. Williams, and B. K. Wershil Stem Cell Factor Influences Mast Cell Mediator Release in Response to Eosinophil-Derived Granule Major Basic Protein Blood, August 1, 1998; 92(3): 1055 - 1061. [Abstract] [Full Text] [PDF]

				W. A. Sewell, L. L. Scurr, H. Orphanides, S. Kinder, and R. I. Ludowyke Induction of Interleukin-4 and Interleukin-5 Expression in Mast Cells Is Inhibited by Glucocorticoids Clin. Vaccine Immunol., January 1, 1998; 5(1): 18 - 23. [Abstract] [Full Text]

				C. Zhang, R. A. Baumgartner, K. Yamada, and M. A. Beaven Mitogen-activated Protein (MAP) Kinase Regulates Production of Tumor Necrosis Factor-alpha and Release of Arachidonic Acid in Mast Cells. INDICATIONS OF COMMUNICATION BETWEEN p38 AND p42 MAP KINASES J. Biol. Chem., May 16, 1997; 272(20): 13397 - 13402. [Abstract] [Full Text] [PDF]